In chronic lymphocytic leukemia (CLL), the most prevalent lymphoid malignancy in western countries, patients have a median age at diagnosis of 72 years. In the last few years, there has been ...

No writing assistance was utilized in the production of this manuscript. The incidence of chronic lymphocytic leukemia (CLL) is dramatically increased in elderly patients although knowledge on how ...

Dr El-Sharkawi's group researches chronic lymphocytic leukemia, rare leukaemias and lymphomas as well as early phase trials and drug development. Dima El-Sharkawi was appointed as a Consultant ...

AstraZeneca has positive data suggesting two fixed-duration combinations containing its Calquence can work in newly diagnosed chronic lymphocytic leukemia (CLL). Calquence, given alongside ...